SCHEMBL3176322

SCHEMBL3176322

CS(=O)(=O)N1CCc2cc(OCCCC3CCN(c4ncc(F)cn4)CC3)ccc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.49
GPR119 Q8TDV5 6/20 0.46
MOGAT2 Q3SYC2 4/20 0.45
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39
RPS6KA5 O75582 1/20 0.39
RPS6KA4 O75676 1/20 0.39
KIT P10721 1/20 0.39
RPS6KB1 P23443 1/20 0.39
CDK2 P24941 1/20 0.39
FLT3 P36888 1/20 0.39
RPS6KA3 P51812 1/20 0.39
RPS6KA2 Q15349 1/20 0.39
RPS6KA1 Q15418 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
RPS6KB2 Q9UBS0 1/20 0.39
RPS6KA6 Q9UK32 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190572 0.92 HRH3 (0.48) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3180603 0.91 GPR119 (0.52) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3181244 0.91 HRH3 (0.51) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3188451 0.90 HRH3 (0.47) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3181162 0.89 KDM4E (0.49) HRH3GPR119MOGAT2
SCHEMBL3182065 0.89 HRH3 (0.46) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3180455 0.89 HRH3 (0.48) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3171529 0.89 HRH3 (0.46) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3181887 0.89 HRH3 (0.46) HRH3GPR119MOGAT2ESR1ESR2
SCHEMBL3171517 0.89 HRH3 (0.46) HRH3GPR119MOGAT2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-01-28 US claimed
EP-2114890-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-11-11 EP claimed
WO-2008097428-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2008-08-14 WO claimed
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-01-28 US disclosed
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-01-28 US disclosed
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-01-28 US disclosed
EP-2114890-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-11-11 EP disclosed
WO-2008097428-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2008-08-14 WO disclosed
WO-2008097428-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2008-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022515-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GCGR, GPR65 HRH3 665/4885GPR119 1/4885MOGAT2 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.